Silo Pharma Inc. has announced that it has received a notification from The Nasdaq Stock Market indicating non-compliance with the minimum bid price requirement, as set forth in Nasdaq Listing Rule 5550(a)(2). The rule requires listed securities to maintain a minimum bid price of $1.00 per share over 30 consecutive business days. This notification, dated June 27, 2025, follows a period from May 14 to June 26, 2025, during which the company's stock price did not meet this threshold. Although the notification does not immediately affect the stock's trading on The Nasdaq Capital Market, Silo Pharma has until December 24, 2025, to regain compliance by achieving a closing bid price of at least $1.00 per share for ten consecutive business days. The company is exploring options, including a reverse stock split, to address this issue. If compliance is not achieved within the initial 180-day period, a further extension may be possible, subject to meeting additional criteria.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.